Australian Sikh fined A$57,000 for underpaying Indian student
Darpan News Desk The Canadian Press, 26 May, 2023 11:15 AM
An Australian court has imposed a penalty of more than A$57,000 on a Melbourne-based painting company owned by a Sikh man for breaches affecting an Indian student working for it.
The Federal Circuit and Family Court on Thursday imposed a A$47,952 penalty against the Mehtaab Group, which operates a business trading as Paint Splash, and A$9,590.04 against the company's sole director and shareholder, Vikramjeet Singh Khalsa.
The penalties were secured by Australian regulatory authority, Fair Work Ombudsman (FWO), which investigated the case after receiving a request for assistance from the affected Indian.
In June 2021, the FWO found that Mehtaab Group unfairly dismissed the worker, following which it ordered the company to pay the worker $21,491 compensation, plus superannuation, within two weeks.
The company failed to make the payments to the Indian, who was employed by the company for almost a year.
During the investigation, a Fair Work Inspector formed a belief that Mehtaab Group failed to pay the worker's accrued but untaken annual leave entitlements when it dismissed her.
In September 2021, the inspector issued Mehtaab Group with a compliance notice, which required the company to calculate and back-pay any outstanding annual leave entitlements owed to the worker.
The Court found the company breached the Fair Work Act by failing to comply with a Fair Work Commission order to pay A$21,491.17 in compensation to the worker as a result of an unfair dismissal claim, and failing to comply with an FWO compliance notice to pay outstanding annual leave entitlements to the worker.
The penalties were imposed against Khalsa after the court found he was involved in both breaches.
In addition to the penalties, the court ordered Mehtaab Group to pay the outstanding Fair Work Commission order for unfair dismissal compensation, plus superannuation, and to calculate and back-pay the annual leave entitlements owing to the worker.
Fair Work Ombudsman Sandra Parker said the regulator was prepared to take action to reinforce the importance of complying with Fair Work Commission orders and FWO compliance notices.
"The Fair Work Ombudsman is prepared to take legal action to ensure that employees receive all compensation and entitlements they are lawfully entitled to. Any employees with concerns about their pay or entitlements should contact the FWO for free advice and assistance."
The FWO has filed 126 litigations involving visa holder workers, and secured more than A$13.4 million in court-ordered penalties in visa holder litigations, in the past five full financial years.
Act 1 came Tuesday, when an 18-year-old gunman, armed with an AR-15 semi-automatic rifle, killed 19 pre-teen children and two teachers in a fourth-grade classroom before dying himself at the hands of law enforcement.
An 18-year-old gunman opened fire Tuesday at a Texas elementary school, killing 14 children, one teacher and injuring others, Gov. Greg Abbott said, and the gunman was dead. It was the deadliest shooting at a U.S. grade school since the shocking attack in Sandy Hook, Connecticut, almost a decade ago.
Cases of the smallpox-related disease have previously been seen only among people with links to central and West Africa. But in the past week, Britain, Spain, Portugal, Italy, U.S., Sweden and Canada all reported infections, mostly in young men who hadn’t previously traveled to Africa.
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.
